COHERENT CORP - COHR 6 07/01/23 (IIVI) Stock Fundamental Analysis
USA - NYSE:IIVI - US19247G2066
227.08 USD
+11.82 (+5.49%)
We assign a fundamental rating of 4 out of 10 to IIVI. IIVI was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. IIVI has only an average score on both its financial health and profitability. IIVI shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
IIVI had positive earnings in the past year.
IIVI had a positive operating cash flow in the past year.
Of the past 5 years IIVI 4 years were profitable.
In the past 5 years IIVI always reported a positive cash flow from operatings.
1.2 Ratios
The profitability ratios for IIVI are negative, so there is not much use analyzing them.
IIVI has a Return On Invested Capital (1.87%) which is in line with its industry peers.
IIVI had an Average Return On Invested Capital over the past 3 years of 4.47%. This is significantly below the industry average of 9.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 1.87% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
1.3 Margins
In the last couple of years the Profit Margin of IIVI has declined.
IIVI has a Operating Margin of 6.00%. This is in the better half of the industry: IIVI outperforms 71.32% of its industry peers.
In the last couple of years the Operating Margin of IIVI has grown nicely.
IIVI has a Gross Margin of 33.06%. This is in the better half of the industry: IIVI outperforms 60.47% of its industry peers.
IIVI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6% | ||
| PM (TTM) | N/A | ||
| GM | 33.06% |
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
2. Health
2.1 Basic Checks
IIVI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IIVI has been increased compared to 1 year ago.
The debt/assets ratio for IIVI is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.57 indicates that IIVI is not in any danger for bankruptcy at the moment.
The Altman-Z score of IIVI (3.57) is better than 60.47% of its industry peers.
IIVI has a debt to FCF ratio of 34.44. This is a negative value and a sign of low solvency as IIVI would need 34.44 years to pay back of all of its debts.
IIVI has a Debt to FCF ratio (34.44) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.58 indicates that IIVI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, IIVI is doing worse than 83.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 34.44 | ||
| Altman-Z | 3.57 |
ROIC/WACC0.2
WACC9.56%
2.3 Liquidity
IIVI has a Current Ratio of 3.08. This indicates that IIVI is financially healthy and has no problem in meeting its short term obligations.
IIVI has a better Current ratio (3.08) than 62.02% of its industry peers.
A Quick Ratio of 1.82 indicates that IIVI should not have too much problems paying its short term obligations.
IIVI has a Quick ratio (1.82) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.08 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The earnings per share for IIVI have decreased by -1.93% in the last year.
IIVI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.68% yearly.
The Revenue has grown by 49.56% in the past year. This is a very strong growth!
Measured over the past years, IIVI shows a very strong growth in Revenue. The Revenue has been growing by 27.82% on average per year.
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%
3.2 Future
IIVI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.68% yearly.
IIVI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.99% yearly.
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 63.97, IIVI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of IIVI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.20, IIVI is valued quite expensively.
Based on the Price/Forward Earnings ratio of 49.50, the valuation of IIVI can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as IIVI.
IIVI is valuated expensively when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.97 | ||
| Fwd PE | 49.5 |
4.2 Price Multiples
IIVI's Enterprise Value to EBITDA is on the same level as the industry average.
60.47% of the companies in the same industry are more expensive than IIVI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 246.31 | ||
| EV/EBITDA | 41.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IIVI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as IIVI's earnings are expected to grow with 15.16% in the coming years.
PEG (NY)23.79
PEG (5Y)3.42
EPS Next 2Y11.05%
EPS Next 3Y15.16%
5. Dividend
5.1 Amount
No dividends for IIVI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COHERENT CORP - COHR 6 07/01/23
NYSE:IIVI (6/30/2023, 8:21:10 PM)
227.08
+11.82 (+5.49%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners0.01%
Inst Owner Change-5.73%
Ins Owners0.76%
Ins Owner Change0%
Market Cap31.65B
Analysts74.55
Price Target203.06 (-10.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-16.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.25%
Min EPS beat(2)-30.58%
Max EPS beat(2)0.07%
EPS beat(4)3
Avg EPS beat(4)-1.48%
Min EPS beat(4)-30.58%
Max EPS beat(4)22.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.63%
Min Revenue beat(2)-9.14%
Max Revenue beat(2)-2.12%
Revenue beat(4)1
Avg Revenue beat(4)-3.03%
Min Revenue beat(4)-9.14%
Max Revenue beat(4)1.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.97 | ||
| Fwd PE | 49.5 | ||
| P/S | 6.54 | ||
| P/FCF | 246.31 | ||
| P/OCF | 53.66 | ||
| P/B | 4.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 41.79 |
EPS(TTM)3.55
EY1.56%
EPS(NY)4.59
Fwd EY2.02%
FCF(TTM)0.92
FCFY0.41%
OCF(TTM)4.23
OCFY1.86%
SpS34.74
BVpS53.46
TBVpS-7.23
PEG (NY)23.79
PEG (5Y)3.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 1.87% | ||
| ROICexc | 2.01% | ||
| ROICexgc | 6.67% | ||
| OM | 6% | ||
| PM (TTM) | N/A | ||
| GM | 33.06% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
ROICexc(3y)6.56%
ROICexc(5y)7.9%
ROICexgc(3y)12.66%
ROICexgc(5y)13.34%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y7.05%
ROICexcg growth 5Y2.62%
ROICexc growth 3Y-2.61%
ROICexc growth 5Y-1.07%
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
F-Score3
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 34.44 | ||
| Debt/EBITDA | 5.26 | ||
| Cap/Depr | 83.67% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.08 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 3.57 |
F-Score3
WACC9.56%
ROIC/WACC0.2
Cap/Depr(3y)75.81%
Cap/Depr(5y)113.17%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%
EBIT growth 1Y-35.57%
EBIT growth 3Y35.66%
EBIT growth 5Y29.99%
EBIT Next Year120.78%
EBIT Next 3Y40.91%
EBIT Next 5Y25.33%
FCF growth 1Y-73.55%
FCF growth 3Y33.72%
FCF growth 5YN/A
OCF growth 1Y-5.44%
OCF growth 3Y32.29%
OCF growth 5Y28.36%